All In Biotech

Free tool

FAERS Monitor: Novolog Mix 70/30 Penfill

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 021172 or its brand name (Novolog Mix 70/30 Penfill, Insulin Aspart Protamine Recombinant, Insulin Aspart Recombinant). Reports on generic versions are filed under their own applications.

Reports

12,980

Serious

10,763

83% of reports

Hospitalization

6,414

Death reported

1,506

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood glucose increased1,265
  • nausea839
  • dyspnoea793
  • hypoglycaemia737
  • vomiting698
  • off label use645
  • drug ineffective532
  • diarrhoea522
  • condition aggravated504
  • abdominal pain500
  • fatigue486
  • dizziness451
  • acute kidney injury448
  • blood glucose decreased423
  • pneumonia423

Reports by year received

View as table
YearReports
200465
200595
2006155
2007243
2008313
2009308
2010215
2011236
2012280
2013225
2014277
2015515
2016526
2017573
2018670
2019622
2020790
20211,050
20221,158
20231,047
20241,159
20251,440
20261,018

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,041,179 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hypoglycaemiaSignal73725.023.316,728
blood glucose decreasedSignal42314.413.15,223
blood glucose increasedSignal1,26510.910.411,449
acute kidney injurySignal4484.84.31,330
abdominal painSignal5003.53.2893
condition aggravatedSignal5042.72.5540
vomitingSignal6982.42.2585
dyspnoeaSignal7932.32.1578
pneumoniaSignal4232.11.9252
nausea8391.71.6261
dizziness4511.51.368
diarrhoea5221.31.239
off label use6451.21.121
fatigue4861.00.90
drug ineffective5320.70.6104

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.